EIGHTH AMENDMENT TO AMENDED AND RESTATED BINDING TERM SHEETBinding Term Sheet • November 14th, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledNovember 14th, 2005 Company Industry
SEVENTH AMENDMENT TO AMENDED AND RESTATED BINDING TERM SHEETBinding Term Sheet • September 9th, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledSeptember 9th, 2005 Company Industry
SIXTH AMENDMENT TO AMENDED AND RESTATED BINDING TERM SHEETBinding Term Sheet • August 1st, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledAugust 1st, 2005 Company Industry
TERM SHEETBinding Term Sheet • May 18th, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledMay 18th, 2005 Company Industry
THIRD AMENDMENT TO AMENDED AND RESTATED BINDING TERM SHEETBinding Term Sheet • April 15th, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledApril 15th, 2005 Company Industry
SECOND AMENDMENT TO AMENDED AND RESTATED BINDING TERM SHEETBinding Term Sheet • February 1st, 2005 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2005 Company Industry
RECITALSBinding Term Sheet • December 30th, 2004 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledDecember 30th, 2004 Company Industry
1. PARTIES Amgen Inc. ("Amgen"), Guilford Pharmaceuticals Inc. ("Guilford") and GPI NIL Holdings, Inc. ("Holdings"). 2. EQUITY On the Closing Date (as defined below), for $20 MM Amgen will purchase 640,095 shares of Guilford Common Stock and 700,000...Binding Term Sheet • September 4th, 1997 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledSeptember 4th, 1997 Company Industry